baber/WOPTO huggingface dataset:
Patent CA-2425787-C (CA)
Inventor: SINGH RANBIR
IPC: H01L29/24
Filed: 2001-11-06
Granted: 2014-09-30
Abstract: La présente invention concerne une terminaison de bord de redresseur Schottky au carbure de silicium, que l'on forme en incluant une zone épitaxiale au carbure de silicium sur une couche de blocage de tension du redresseur Schottky et à proximité d'un contact Schottky du redresseur Schottky au carbure de silicium. La couche épitaxiale au carbure de silicium peut présenter une épaisseur et un niveau de dopage tels qu'elle fournit une charge dans la zone épitaxiale au carbure de silicium qui est fonction du dopage superficiel de la couche de blocage. La zone épitaxiale au carbure de silicium peut former un contact non ohmique avec le contact Schottky. La zone épitaxiale au carbure de silicium peut posséder une largeur comprise entre environ 1,5 et environ 5 fois l'épaisseur de la couche de blocage. L'invention se rapporte également à des redresseurs Schottky dotés de la terminaison de bord précitée et à des procédés de fabrication de la terminaison de bord et des redresseurs précités. Les procédés de l'invention peuvent également améliorer de manière avantageuse les performances des dispositifs obtenus et simplifier leur processus de fabrication.
Patent CA-2431177-C (CA)
Inventor: MARGOLIN JUDITH F
IPC: C07K14/71
Filed: 2001-12-07
Granted: 2015-04-14
Abstract: The present invention relates to a soluble receptor variant of TREM-1. More particularly, present invention relates to methods of modulating an immune response by administering variants of TREM-1.
Patent CA-2433337-C (CA)
Title: Compositions containing optical diffusing pigments
Inventor: TAN MANUEL L
IPC: A61K8/26
Filed: 2001-12-20
Granted: 2009-12-01
Abstract: The present invention provides a method of preventing the appearance of fine lines, wrinkles and discoloration on the skin. This is achieved by the topical application to the skin of a composition containing a first platelet of alumina treated with a metal oxide, a second platelet treated with a spherical scattering component, and a cosmetic or pharmaceutical carrier. The compositions can also contain a standard interference pigment, such as a white and a yellow interference pigment to further blend the color to closely match the natural skin tone. The combination of pigments and platelets creates a mosaic of color and optically manipulates light such that lines, wrinkles, disfigurations and discolorations on the skin appear to substantially vanish. In addition to the pigments and platelet components, a non-interference pigment can also be added to fine-tune the matching of color to the skin tone. The alumina platelet alone is metallic-looking; however, when it is tempered with the other platelet containing the spherical scattering component, the net effect is that the skin appears natural, luminous and flawless.
Patent CA-2438812-C (CA)
Inventor: JONES HAZEL L
IPC: A47K11/02
Filed: 2003-08-27
Granted: 2006-08-08
Abstract: Un assemblage pour toilette gonflable et jetable pour disposer d'une toilette portative à utiliser en particulier lors d'un voyage. L'assemblage pour toilette gonflable et jetable comprend un réceptacle ayant un compartiment de stockage installé à l'intérieur et ayant également une cloison, un mur extérieur, une chambre à air disposée entre la paroi interne et la paroi externe, et une ouverture placée à travers un point haut du réceptacle dans le compartiment de stockage; l'assemblage comprend également un rabat ayant une extrémité solidement attachée au réceptacle et pouvant être fermé par-dessus l'ouverture du réceptacle; il comprend enfin une soupape d'air placée dans une extrémité du réceptacle à travers le mur extérieur dans la chambre à air.
Patent CA-2439797-C (CA)
Inventor: AALTO JUHA
IPC: F41G1/387
Filed: 2002-03-05
Granted: 2009-05-26
Abstract: A rapid clamping base for an open rifle sights, the base consisting of two clamping frames, a front frame (1) and a rear frame (2), whose clamping rings (3,4) retain the sight (5). The frames can be clamped by means of a rapid retainer to a two-piece clamping rail (6, 7) in a gun, such as a sporting gun.  The claws (8, 9) provided in the front frame (1) for engagement with the clamping rail (6) are provided at differ- ent locations relative to the longitudinal direction of the rail so as to be pressed in engagement with the edges of the rail when the optic sight (5) is turned in the hori- zontal plane from the lateral direction (10) to the central line of the gun. The front frame (1) also comprises a support tongue (11) extending downwardly and bearing against the rear edge of the front clamping rail (6). The rear frame (2) comprises second claws (12, 13) engaging the clamping rail (7), one claw (12) being solidly mounted in the rear frame and the other, i.e. the clamping claw (13) being movable and in position to be pressed against the edge of the rail. The rear frame (2) also comprises a support tongue (14) extending downwards and bearing against the front edge of the rear clamping rail (7), both of the frames thus having three pressing points on the clamping rails.
Patent CA-2441652-C (CA)
Inventor: EFRATI SHAI
IPC: A61M16/04
Filed: 2002-03-21
Granted: 2009-09-29
Abstract: An intubation method and system including the insertion of an endotracheal tube into a patient airway, inflating an cuff associated with the endotracheal tube at a location in the patient airway below the vocal cords, monitoring carbon dioxide concentration in the patient airway at a carbon dioxide monitoring location between the cuff and the vocal cords and adjusting inflation of the cuff based at least in part on the monitoring in order that the cuff inflation generally prevents leakage of carbon dioxide past the cuff.
Patent CA-2449485-C (CA)
Inventor: DI PIERRO FRANCESCO
IPC: A61K8/55
Filed: 2002-05-16
Granted: 2010-09-28
Abstract: L'invention concerne des compositions pharmaceutiques et/ou cosmétiques contenant une combinaison des principes actifs suivants: a) un complexe d'escine/betâ-sitosterol avec des phospholipides, b) un complexe de flavonoïdes dimères de <i>Gingko biloba</i> avec des phospholipides, c) un complexe de triterpènes de <i>Centella asiatica</i> avec des phospholipides, et, éventuellement, l'une ou l'autre de ces substances ou les deux à la fois: d) éthyl ximéninate, e) extrait standardisé de <i>Coleus forskolii</i>.
Patent CA-2453470-C (CA)
Title: Utilisation de follistatine pour le traitement de la fibrogenese hepatique
Inventor: PHILLIPS DAVID
IPC: A61K45/00
Filed: 2002-07-12
Granted: 2014-02-04
Abstract: La présente invention concerne des compositions pharmaceutiques pour le traitement et/ou la prophylaxie d'une affection associée à la fibrose chez un vertébré, laquelle composition comprend au moins un antagoniste de l'activine, et éventuellement, un vecteur pharmaceutiquement acceptable, un adjuvant et/ou un diluant. L'invention concerne également des traitements d'une affection associée à la fibrose chez un vertébré, ainsi que des procédés et nécessaires destinés au diagnostic de tels états.
Patent CA-2461173-C (CA)
Title: Movable barrier operator
Inventor: WANIS PAUL E
IPC: H02P7/00
Filed: 1999-09-24
Granted: 2007-02-13
Abstract: A movable barrier operator having improved safety and energy efficiency features automatically detects Fine voltage frequency and uses that information to set a worklight shut-off time. The operator automatically detects the type of door (single panel or segmented) and uses that information to set a maximum speed of door travel. The operator moves the door with a linearly variable speed from start of travel to stop for smooth and quiet performance. The operator provides for full door closure by driving the door into the floor when the DOWN limit is reached and no auto-reverse condition has been detected. The operator provides for user selection of a minimum stop speed for easy starting and stopping of sticky or binding doors.
Patent CA-2461601-C (CA)
Inventor: THOMPSON WALTER
IPC: D01H1/22
Filed: 2003-07-29
Granted: 2011-11-29
Abstract: A flyer bow machine for twinning or twisting wire or cable is provided in which a moving carrier strip is provided on the flyer bow. The carrier strip moves along the bow in the same direction as the wire or cable is traveling, and preferably, moves at the same speed as the wire or cable. As a result, tension on the wire or cable as it passes though the flyer bow machine is reduced. Thus, higher throughput rates of wire or cable, or improved quality of wire or cable, can be achieved.
Patent CA-2469264-C (CA)
Title: Dispositif d'ancrage de poteau
Inventor: BERGMAN RICHARD
IPC: E02D27/00
Filed: 2004-05-17
Granted: 2011-04-12
Abstract: L'invention concerne une méthode d'ancrage de poteau pour ancrer des poteaux utilisés dans des applications de clôture, de terrasse, de balcon et de rampe à une surface où un appareil d'ancrage comprenant un élément de base pour fixer à la surface et un élément tubulaire allongé qui est connecté à l'élément de base et qui est muni d'un embout éloigné de l'élément de base avec un bord capable de percer le poteau; et ensuite, les étapes suivantes sont effectuées peut importe l'ordre : (a) fixer l'élément de base à la surface à un emplacement où le poteau doit être situé et (b) aligner longitudinalement le poteau sur l'élément tubulaire, contigu à une extrémité du poteau à l'extrémité terminale, et forcer l'élément tubulaire dans le poteau pour essentiellement empaler le poteau de façon que les surfaces de l'élément tubulaire établissent un contact par friction avec le poteau.
Patent CA-2475857-C (CA)
Title: Named entity translation
Inventor: AL-ONAIZAN YASER
IPC: G06F40/00
Filed: 2003-03-11
Granted: 2008-12-23
Abstract: Translating named entities (110) from a source language to a target language. In general, in one implementation, the technique includes: generating potential translations of a named entity from a source language to a target language using a pronunciation-based and spelling-based transliteration model (210), searching a monolingual resource (220) in the target language for information relating to usage frequency, and providing output including at least one of the potential translations based on the usage frequency (230).
Patent CA-2476935-C (CA)
Inventor: KUWANO MITSUAKI
IPC: A61K47/32
Filed: 2003-02-21
Granted: 2013-05-28
Abstract: The present invention provides an excellent drug delivery system to posterior segments. An injection according to the present invention is a subconjunctival injection which comprises fine particles containing a drug and enables the drug to deliver to the posterior segments. The drug can be efficiently delivered to the posterior segments (such as a retina, a choroid and an optic nerve) while scarcely injuring ophthalmic tissues by administering the fine particles containing the drug subconjunctivally Preferred fine particles are made of a synthetic biodegradable polymer, their average particle dispersed in the fine particles uniformly. Preferred diameter is 50 nm to 150 µ m, and the drug is drugs are anti-inflammatories, immunosuppressors, antivirals, anticancer drugs, angiogenesis inhibitors, optic neural protectants, antimicrovials and antifungal .agents.
Patent CA-2477769-C (CA)
Title: Ophthalmic composition comprising ascomycin
Inventor: BABIOLE SAUNIER MAGGY
IPC: A61K9/00
Filed: 2003-03-03
Granted: 2011-01-18
Abstract: This invention relates to topical ophthalmic compositions comprising an ascomycin e.g. for the treatment of inflammatory diseases such as blepharitis.
Patent CA-2480717-C (CA)
Inventor: SAWYER ALAN MICHAEL
IPC: C07K16/00
Filed: 2003-04-17
Granted: 2012-08-21
Abstract: La présente invention concerne des procédés de production d'anticorps monoclonaux. L'invention concerne en particulier des procédés de haut débit permettant de produire et dépister des anticorps monoclonaux de manière plus rapide que par des procédés conventionnels.
Patent CA-2485596-C (CA)
Inventor: LIU QIANG
IPC: C12N15/09
Filed: 2003-05-09
Granted: 2013-04-16
Abstract: A novel method of pyrophosphorolysis activated polymerization (PAP) has been developed. In PAP, pyrophosphorolysis and polymerization by DNA polymerase are coupled serially for each amplification by using an activatable oligonucleotide P* that has a non-extendible 3'-deoxynucleotide at its 3' terminus. PAP can be applied for exponential amplification or for linear amplification. PAP can be applied to amplification of a rare allele in admixture with one or more wild-type alleles by using an activatable oligonucleotide P* that is an exact match at its 3' end for the rare allele but has a mismatch at or near its 3' terminus for the wild-type allele. PAP is inhibited by a mismatch in the 3' specific sequence as far as 16 nucleotides away from the 3' terminus. PAP can greatly increase the specificity of detection of an extremely rare mutant allele in the presence of the wild-type allele. Specificity results from both pyrophosphorolysis and polymerization since significant nonspecific amplification requires the combination of mismatch pyrophosphorolysis and misincorporation by the DNA polymerase, an extremely rare event. Using genetically engineered DNA polymerases greatly improves the efficiency of PAP.
Patent CA-2486883-C (CA)
Inventor: BECH SOMMER MICHAEL
IPC: C07D209/10
Filed: 1998-05-07
Granted: 2009-04-28
Abstract: A process of manufacturing sertindole comprising preparation of N-(4- fluorophenyl)-N-(2-carboxy-4-chlorophenyl)glycine, by reacting an alkalimetal salt of 2,5-dichlorobenzoic acid with an alkalimetal salt of N-(4- fluorophenyl)glycine in an aqueous, alkaline environment in the presence of a copper catalyst; cyclisation of N-(4-fluorophenyl)-N-(2-carboxy-4- chlorophenyl)glycine to the corresponding 3-acetoxy-indole; reduction of the 3- acetoxy-indole and subsequent elimination of H2O thereby obtaining 5-chloro-1- (4-fluorophenyl)indole which is reacted with 4-piperidone in a mixture of an acetic acid and concentrated HCI; reduction of the resulting 5-chloro-1-(4- fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole and reaction of this compound with 1-(2-chloroethyl)-2-imidazolidinon in order to obtain sertindole. Alternatively, 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4- yl)indole is first reacted with 1-(2-chloroethyl)-2-imidazolidinon followed by reduction thereby obtaining sertindole. This process uses reactants and solvents that are suitable and allowed in large scale manufacture. Furthermore good total yields are obtained.
Patent CA-2487707-C (CA)
Inventor: REINHOLD WALTER
IPC: A61N1/32
Filed: 2004-11-02
Granted: 2013-06-11
Abstract: In an apparatus for electrotherapy, comprising a circuit arrangement with a terminal for generation of a sequence of voltage pulses and two electrodes for application of these voltage pulses to a part of the body that is to be treated; one of the two electrodes having a surface of comparatively high transition resistance and the other electrode having comparatively low transition resistance towards human skin; the electrode with the surface of high transition resistance being movable over the treated part of the body and the surface being a plastic film; with sequences of pulses of voltages from 1 to 600 V being generated and a current in a microampere range being produced in the tissue; it is provided that the rapid discharge circuit comprises several thyristors which are triggered by optocouplers.
Patent CA-2497623-C (CA)
Title: Implant comprising a two-piece joint
Inventor: BAUMGARTNER DANIEL
IPC: A61F2/30
Filed: 2002-09-18
Granted: 2011-05-17
Abstract: An implant, in particular an intervertebral implant, comprising (A) two articulating parts (4; 5) having each a central axis (1; 26), each a curved slide surface (6; 7) intersecting the central axes (1; 26), and each an axially outermost end (14;  15) that can be connected to a bone, where (B) the slide surfaces (6; 7) are curved and displaceable one on the other, where (D) the second articulating part (5) is rotatable about two mutually skewed axes of rotation (10; 11) relative to the first articulating part (4).
Patent CA-2505509-C (CA)
Title: Procede et sondes de detection d'une proteine de fusion specifique a une tumeur
Inventor: VAN DONGEN JACOBUS JOHANNES MARIA
IPC: G01N33/542
Filed: 2003-11-06
Granted: 2013-08-20
Abstract: L'invention se rapporte à la détection de protéines de fusion et à un ensemble d'au moins une première et une seconde sondes moléculaires, chacune présentant un colorant permettant le transfert d'énergie une fois les colorants assemblés ; au moins une sonde pourvue d'un groupe réactif permettant la juxtaposition d'au moins une des deux sondes, ledit groupe réactif permettant de moduler la juxtaposition desdites sondes de manière à augmenter la probabilité de transfert d'énergie entre lesdits colorants. L'invention concerne en outre un procédé permettant de détecter la présence d'un protéine de fusion dans une cellule au niveau d'une seule cellule.
Patent CA-2510114-C (CA)
Inventor: PARRETT DALE H
IPC: B26D1/26
Filed: 2005-06-17
Granted: 2008-09-09
Abstract: A cutting assembly including a pair of substantially parallel shafts, each shaft having a plurality of axially spaced cutting blades mounted thereon such that each blade forms an oblique angle with respect to a central axis of the associated shaft, wherein each cutting blade includes a central body having a plurality of teeth radially spaced thereabout.
Patent CA-2514184-C (CA)
Inventor: CAO LIANGXIAN
IPC: A61K45/00
Filed: 2004-01-21
Granted: 2016-04-12
Abstract: The present invention relates to methods for identifying compounds that modulate untranslated region-dependent expression of a target gene. The invention particularly relates to using untranslated regions of a target gene or fragments thereof linked to a reporter gene to identify compounds that modulate untranslated region-dependent expression of a target gene. The methods of the present invention provide a simple, sensitive assay for high-throughput screening of libraries of compounds to identify pharmaceutical leads.
Patent CA-2517809-C (CA)
Title: Methode d'etalonnage automatique pour systeme de detection des rates d'un moteur a combustion
Inventor: WU ZHIJIAN JAMES
IPC: F02D45/00
Filed: 2005-08-31
Granted: 2007-07-03
Abstract: n système pour étalonner systématiquement un système de détection de ratés d'allumage de moteur pour un moteur à combustion interne. La présente invention prévoit un procédé de collecte d'une pluralité de groupes de points de données échantillons. Chacun des groupes de points de données échantillons représente un événement d'allumage de cylindre. Facultativement, des évènements de ratés d'allumage peuvent être induits durant la collecte des groupes de points de données échantillons. En utilisant les points de données collectés, une pluralité de paramètres de compensation est ensuite générée et appliquée de manière itérative aux points de données échantillons afin d'optimiser généralement la détection des occurrences de ratés d'allumage. Des paramètres de compensation qui produisent une détection de ratés d'allumage de haute précision sont sélectionnés et peuvent être exportés à partir du système d'étalonnage pour le transport vers un système de commande de moteur dans un moteur à combustion interne. La compensation d'erreur bord à bord dans les données de vitesse du moteur, le bruit du moteur, l'amplitude de signal de ratés d'allumage et les coefficients de limite de zone de filtrage améliorent la qualité de signal et améliorent davantage la détection de ratés d'allumage.
Patent CA-2523253-C (CA)
Title: Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
Inventor: DILLON MICHAEL PATRICK
IPC: A61K31/4178
Filed: 2004-04-30
Granted: 2010-06-22
Abstract: This invention relates to compounds which are alpha- 1 receptor agonists, preferably alpha-1A/L receptor agonists, and which are represented by Formula (I), wherein m, A, X, Y, R1, R2, R3, R4 and R5 are as defined in the specification; or individual isomers, racemic or non~racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.
Patent CA-2526421-C (CA)
Inventor: TAL MICHAEL G
IPC: A61B/
Filed: 2004-05-20
Granted: 2011-09-20
Abstract: An apparatus for the treatment of venous stasis includes an elongated intraluminal member shaped and dimensioned for passage through vessels of a subject. The intraluminal member includes a proximal end and a distal end. A  conduit extends from proximate the proximal end of the intraluminal member to proximate the distal end of the intraluminal member. The conduit is shaped and dimensioned for fluid communication between the proximal end of the intraluminal member and the distal end of the intraluminal member. The distal end of the intraluminal member includes disruption means proximate thereto for ablating a predetermined vessel wall. A method is also provided for the treatment of venous stasis. The method is achieved by advancing an elongated intraluminal member through a vein to a treatment site, activating the intraluminal member for ablation of the treatment site and injecting sclerosant into the vein at the treatment site.
Patent CA-2529575-C (CA)
Title: Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
Inventor: WHITE HILLARY D
IPC: A61K31/57
Filed: 2004-06-15
Granted: 2012-04-10
Abstract: Compositions and methods for alleviating the symptoms associated with chronic fatigue syndrome and fibromyalgia syndrome are provided. The compositions are based on use of a transdermal gel formulation delivery system for androgens, either alone or in combination with other hormones.
Patent CA-2531174-C (CA)
Inventor: GRABAU PETER
IPC: F03D1/00
Filed: 2004-07-09
Granted: 2011-03-08
Abstract: A method of transporting and storing a wind turbine blade (1) including a blade root (10) and a blade tip (4), where the wind turbine blade curves in the unloaded state in such a manner that the blade (1) presents a substantially concave face (30) and a substantially convex face (12), and such that said blade tip (4) is spaced apart from the longitudinal central axis (28) of said blade root (10). By the method, the wind turbine blade (1) is prestressed by means (2, 5, 6, 9, 13, 16, 17, 21, 22, 23, 24, 25, 26, 33) at a distance from the blade root (10) in such a manner that the blade tip (4) is brought closer to the longitudinal central axis (28) of the blade root (10).  The invention also relates to a curved wind turbine blade (1) being provided with inner ballast tanks (21) at a distance from the blade root (10), whereby the blade is prestressed by filling said ballast tanks in such a manner that the blade tip (4) may be brought closer to the longitudinal central axis (28) of the blade root (10). The invention further relates to an apparatus including prestressing means for loading a curved blade at a distance from the blade root (10) in such a manner that the blade tip (4) is brought closer to the longitudinal central axis (28) of the blade root (10).
Patent CA-2535362-C (CA)
Inventor: YAMAHIRA SATOKO
IPC: A23L33/00
Filed: 2004-08-18
Granted: 2013-03-19
Abstract: It is intended to provide a lactic acid bacterium selected from the group consisting of Lactobacillus ONRIC b0239 (FERM BP-10064) and Lactobacillus ONRIC b0240 (FERM BP-10065); and a composition (in particular, a composition in the form of a food, a drink or a drug) containing the lactic acid bacterium and having a mucosal immunopotentiation effect. The above-described lactic acid bacterium and the composition containing the same can exert an excellent mucosal immunopotentiation effect and, therefore, are useful in strengthening the biological defense system.